AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-199067315/telavancin-withdrawal-marketing-authorization.html" title="Facts and information about Telavancin: withdrawal of marketing authorization application.(Regulatory Action and News)(Brief article)">Telavancin: withdrawal of marketing authorization application.(Regulatory Action and News)(Brief article)</a>
Close
Set up an RSS feed that alerts you when new articles from WHO Drug Information are available.
Frequently asked questions about RSS feeds
Telavancin: withdrawal of marketing authorization application.(Regulatory Action and News)(Brief article)
European Union -- The European Medicines Agency (EMEA) has been formally notified of the decision to withdraw the application for a centralized marketing authorization for the medicinal product telavancin (Vibativ[R]) 15 mg/ml powder for concentrate for solution for infusion.
Vibativ[R] was expected to be used for the treatment of complicated skin and soft tissue …
Related articles from newspapers, magazines, journals, and more
-
- Prolia (denosumab) granted marketing authorization in the European Union.
-
News wire article from: Chemical Business Newsbase
May 28, 2010
700+ words
-
- Press Release: CPMP recommends granting marketing authorization in the...
-
News wire article from: Chemical Business Newsbase
March 12, 2002
700+ words
-
- Press Release: Marketing authorization application submitted in European...
-
News wire article from: Asia Africa Intelligence Wire
September 20, 2002
700+ words
-
- Eisai to submit marketing authorization applications in the US and European...
-
News wire article from: Chemical Business Newsbase
January 25, 2011
700+ words
-
- Tercica submits Marketing Authorization Application for Increlex in the...
-
News wire article from: Chemical Business Newsbase
December 7, 2005
700+ words
